Table 4:
Comparison between 1999 and 2006, 2007 and 2013 and 2014 and 2020
| 1999–2006 (n = 23) | 2007–2013 (n = 7) | 2014–2020 (n = 16) | Global (n = 46) | |
|---|---|---|---|---|
| Age, median (IQR) | 40 (29 to 47) | 56 (24 to 64) | 57 (25 to 63) | 42 (27 to 59) |
| Males (%), n (%) | 21 (91.3) | 5 (71.4) | 7 (43.8) | 33 (71.7) |
| Hypertension (%), n (%) | 8 (34.7) | 5 (71.4) | 4 (25) | 17 (37) |
| Dislipidaemia (%), n (%) | 3 (13) | 2 (28.6) | 2 (12.5) | 7 (15.2) |
| PAD (%), n (%) | 2 (8.7) | 1 (14.2) | 1 (6.3) | 4 (8.7) |
| Psychiatric disorders (%), n (%) | 0 (0) | 2 (28.6) | 3 (18.8) | 5 (10.9) |
| CAD (%), n (%) | 2 (8.7) | 2 (28.6) | 1 (6.3) | 5 (10.9) |
| Renal failure (%), n (%) | 0 (0) | 0 (0) | 1 (6.3) | 1 (3.6) |
| ISS, median (IQR) | 43 (42 to 46) | 50 (27 to 55) | 43 (41 to 50) | 43 (41 to 50) |
| Urgent procedures (%), n (%) | 10 (43.5) | 6 (85.7) | 16 (100) | (69.6) |
| Time between admission and intervention (h), median (IQR), n (%) | 24 (2 to 120) | 1.8 (1.8 to 80) | 2 (1 to 3.9) | 2.7 (1.7 to 27.7) |
| TEVAR (%), n (%) | 17 (73.9) | 7 (100) | 16 (100) | 40 (87) |
| Coverage of the LSA (%)—only TEVAR, n (%) | 6 (35.2) | 4 (57.1) | 12 (75) | 22 (55) |
| Percutaneous femoral access (%) (only TEVAR), n (%) | 1 (5.8) | 2 (28.5) | 7 (43.6) | 10 (25) |
| Proximal oversizing, median (IQR) | 5 (1 to 17) | 5 (4 to 16) | 10 (7 to 18) | 8 (5 to 18) |
| Distal oversizing, median (IQR) | 22 (−8 to 25) | 36 (14 to 40) | 32 (19 to 44) | 29 (17 to 44) |
| In-hospital mortality (%), n (%) | 6 (26.1) | 2 (28.6) | 1 (6.3) | 9 (20) |
| All-cause in-hospital complications, n (%) | 23 (100) | 7 (100) | 13 (81.3) | 43 (93.5) |
| Aortic-related complications, n (%) | 7 (30.5) | 3 (42.9) | 0 (0) | 10 (21.7) |
CAD: coronary artery disease; ISS: injury severity score; IQR: interquartile range; LSA: left subclavian artery; PAD: peripheral arterial disease; TEVAR: thoracic endovascular repair.